La cadena de opciones muestra datos clave de las opciones de acciones de Evaxion a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Evaxion..

Evaxion (NASDAQ:EVAX) Bolsa, Cadena de Opciones

EVAXION A/S

Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ACTG

ALUR

BTAI

CNTA

DALN

DWTX

EVAX

FFBC

HYZN

LITM

MLYS

NVNI

PBBK

SEPN

STBX

TRUG

TWLO

Twilio sube un 18,5% tras superar expectativas de ingresos. Explora los movimientos clave del mercado previo de hoy.

Acciones de Twilio (TWLO) se disparan más de un 18%; 20 acciones que se mueven en el premercado de EE.UU.

IDAI

INTZ

LIDR

LKCO

LUXH

MGIH

MLGO

MRBK

MTRX

NEUP

ONDS

QRHC

RVSN

SLDP

VIRX

WTBA

Descubre las acciones que lideran los movimientos en la apertura del mercado, incluyendo repuntes destacados y caídas sorprendentes.

Acciones de Evaxion Biotech (EVAX) suben alrededor del 62%; 20 acciones que se mueven en el premercado

Long Ideas

AREN

CSTM

GDYN

GEAR

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este viernes: CSTM, VIRX, EVAX, AREN y GDYN.

5 acciones en el foco este viernes: CSTM, VIRX, EVAX, AREN y GDYN

Evaxion AS

WIIM

Evaxion股票交易下跌，因为该公司报告了Q2销售结果同比下降。

Evaxion Biotech Reports Q2 2025 Financial Results

Evaxion Biotech: Promising Developments and Strategic Collaborations Support Buy Rating with $14 Price Target

Evaxion A/S 2025 Q2 - Results - Earnings Call Presentation

Evaxion A/S (EVAX) Q2 2025 Earnings Call Transcript

Press Releases

Evaxion to present at several conferences during the second half of 2025

Evaxion A/S General Corporate Statement By Foreign Issuer (Form6)

Evaxion Announces Conference Participation for H2 2025

Abpro Hldgs

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Ainos

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Curis

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Edesa Biotech

Evaxion

Geovax Labs

iBio

Imunon

Longeveron

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Lisata Therapeutics

MetaVia

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

Neuphoria Therapeutics Inc. - Common Stock

Neuphoria Therapeutics

Nanoviricides

OSR Holdings

BiomX

Portage Biotech

Q32 Bio

SAB Biotherapeutics

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Synlogic

HC Wainwright & Co.

Lake Street

Ladenburg Thalmann

Oppenheimer

Comments

Evaxion

Evaxion (EVAX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL